vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and MEDIFAST INC (MED). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $75.1M, roughly 1.4× MEDIFAST INC). On growth, CARRIAGE SERVICES INC posted the faster year-over-year revenue change (8.0% vs -36.9%). CARRIAGE SERVICES INC produced more free cash flow last quarter ($6.2M vs $-6.6M). Over the past eight quarters, CARRIAGE SERVICES INC's revenue compounded faster (1.0% CAGR vs -34.4%).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

CSV vs MED — Head-to-Head

Bigger by revenue
CSV
CSV
1.4× larger
CSV
$105.5M
$75.1M
MED
Growing faster (revenue YoY)
CSV
CSV
+44.9% gap
CSV
8.0%
-36.9%
MED
More free cash flow
CSV
CSV
$12.8M more FCF
CSV
$6.2M
$-6.6M
MED
Faster 2-yr revenue CAGR
CSV
CSV
Annualised
CSV
1.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
MED
MED
Revenue
$105.5M
$75.1M
Net Profit
$12.3M
Gross Margin
34.8%
69.4%
Operating Margin
23.3%
-10.4%
Net Margin
11.6%
Revenue YoY
8.0%
-36.9%
Net Profit YoY
24.5%
EPS (diluted)
$0.76
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
MED
MED
Q4 25
$105.5M
$75.1M
Q3 25
$102.7M
$89.4M
Q2 25
$102.1M
$105.6M
Q1 25
$107.1M
$115.7M
Q4 24
$97.7M
$119.0M
Q3 24
$100.7M
$140.2M
Q2 24
$102.3M
$168.6M
Q1 24
$103.5M
$174.7M
Net Profit
CSV
CSV
MED
MED
Q4 25
$12.3M
Q3 25
$6.6M
$-2.3M
Q2 25
$11.7M
$2.5M
Q1 25
$20.9M
$-772.0K
Q4 24
$9.9M
Q3 24
$9.9M
$1.1M
Q2 24
$6.3M
$-8.2M
Q1 24
$7.0M
$8.3M
Gross Margin
CSV
CSV
MED
MED
Q4 25
34.8%
69.4%
Q3 25
35.3%
69.5%
Q2 25
35.2%
72.6%
Q1 25
35.3%
72.8%
Q4 24
34.4%
74.1%
Q3 24
35.2%
75.4%
Q2 24
36.2%
73.2%
Q1 24
36.0%
72.8%
Operating Margin
CSV
CSV
MED
MED
Q4 25
23.3%
-10.4%
Q3 25
17.0%
-4.6%
Q2 25
23.5%
-1.0%
Q1 25
29.5%
-1.1%
Q4 24
21.6%
0.6%
Q3 24
22.7%
1.5%
Q2 24
18.0%
-4.7%
Q1 24
18.8%
4.5%
Net Margin
CSV
CSV
MED
MED
Q4 25
11.6%
Q3 25
6.4%
-2.5%
Q2 25
11.5%
2.3%
Q1 25
19.5%
-0.7%
Q4 24
10.1%
Q3 24
9.8%
0.8%
Q2 24
6.1%
-4.8%
Q1 24
6.7%
4.8%
EPS (diluted)
CSV
CSV
MED
MED
Q4 25
$0.76
$-1.64
Q3 25
$0.41
$-0.21
Q2 25
$0.74
$0.22
Q1 25
$1.34
$-0.07
Q4 24
$0.62
$0.08
Q3 24
$0.63
$0.10
Q2 24
$0.40
$-0.75
Q1 24
$0.45
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
MED
MED
Cash + ST InvestmentsLiquidity on hand
$1.7M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$254.8M
$198.9M
Total Assets
$1.3B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
MED
MED
Q4 25
$1.7M
$167.3M
Q3 25
$1.2M
$173.5M
Q2 25
$1.4M
$162.7M
Q1 25
$4.6M
$164.6M
Q4 24
$1.2M
$162.3M
Q3 24
$1.3M
$170.0M
Q2 24
$1.5M
$163.5M
Q1 24
$1.7M
$156.4M
Stockholders' Equity
CSV
CSV
MED
MED
Q4 25
$254.8M
$198.9M
Q3 25
$242.1M
$214.7M
Q2 25
$235.4M
$216.0M
Q1 25
$223.1M
$211.0M
Q4 24
$208.6M
$210.1M
Q3 24
$198.1M
$207.3M
Q2 24
$187.9M
$205.3M
Q1 24
$179.6M
$211.0M
Total Assets
CSV
CSV
MED
MED
Q4 25
$1.3B
$248.0M
Q3 25
$1.3B
$268.2M
Q2 25
$1.3B
$269.3M
Q1 25
$1.3B
$280.0M
Q4 24
$1.3B
$284.2M
Q3 24
$1.3B
$291.2M
Q2 24
$1.3B
$293.5M
Q1 24
$1.3B
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
MED
MED
Operating Cash FlowLast quarter
$14.1M
$-5.3M
Free Cash FlowOCF − Capex
$6.2M
$-6.6M
FCF MarginFCF / Revenue
5.9%
-8.8%
Capex IntensityCapex / Revenue
7.5%
1.8%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
MED
MED
Q4 25
$14.1M
$-5.3M
Q3 25
$24.7M
$12.1M
Q2 25
$8.1M
$-3.4M
Q1 25
$13.8M
$3.4M
Q4 24
$9.3M
$-4.9M
Q3 24
$20.9M
$9.1M
Q2 24
$2.2M
$13.1M
Q1 24
$19.7M
$7.3M
Free Cash Flow
CSV
CSV
MED
MED
Q4 25
$6.2M
$-6.6M
Q3 25
$18.0M
$10.8M
Q2 25
$5.2M
$-4.8M
Q1 25
$10.6M
$1.9M
Q4 24
$4.9M
$-7.2M
Q3 24
$16.2M
$7.7M
Q2 24
$-1.4M
$11.1M
Q1 24
$16.2M
$5.4M
FCF Margin
CSV
CSV
MED
MED
Q4 25
5.9%
-8.8%
Q3 25
17.5%
12.0%
Q2 25
5.1%
-4.5%
Q1 25
9.9%
1.6%
Q4 24
5.0%
-6.1%
Q3 24
16.1%
5.5%
Q2 24
-1.4%
6.6%
Q1 24
15.6%
3.1%
Capex Intensity
CSV
CSV
MED
MED
Q4 25
7.5%
1.8%
Q3 25
6.5%
1.5%
Q2 25
2.8%
1.3%
Q1 25
3.0%
1.3%
Q4 24
4.5%
1.9%
Q3 24
4.6%
1.0%
Q2 24
3.5%
1.1%
Q1 24
3.4%
1.1%
Cash Conversion
CSV
CSV
MED
MED
Q4 25
1.15×
Q3 25
3.76×
Q2 25
0.69×
-1.36×
Q1 25
0.66×
Q4 24
0.94×
Q3 24
2.11×
8.04×
Q2 24
0.34×
Q1 24
2.83×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

MED
MED

Segment breakdown not available.

Related Comparisons